tiprankstipranks
enVVeno Medical (NVNO)
NASDAQ:NVNO

enVVeno Medical (NVNO) Stock Price & Analysis

299 Followers

NVNO Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$2.51 - $6.97
Previous Close$5.28
Volume54.44K
Average Volume (3M)132.85K
Market Cap
$70.31M
Enterprise Value$25.30M
Total Cash (Recent Filing)$46.41M
Total Debt (Recent Filing)$1.40M
Price to Earnings (P/E)-2.6
Beta0.70
Apr 29, 2024
Next Dividend Ex-DateN/A
Expense RatioN/A
Share Statistics
EPS (TTM)-2.02
Shares Outstanding13,317,000
10 Day Avg. Volume88,470
30 Day Avg. Volume132,853
Standard Deviation0.24
R-Squared0.07
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)1.57
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-3.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-2.60
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Ownership Overview

17.07%3.25%27.51%52.16%
17.07% Insiders
27.51% Other Institutional Investors
52.16% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks

NVNO FAQ

What was enVVeno Medical’s price range in the past 12 months?
enVVeno Medical lowest stock price was $2.51 and its highest was $6.97 in the past 12 months.
    What is enVVeno Medical’s market cap?
    Currently, no data Available
    When is enVVeno Medical’s upcoming earnings report date?
    enVVeno Medical’s upcoming earnings report date is Apr 29, 2024 which is in 31 days.
      How were enVVeno Medical’s earnings last quarter?
      enVVeno Medical released its earnings results on Mar 25, 2024. The company reported -$0.24 earnings per share for the quarter, the consensus estimate of -$0.24 by $0.
        Is enVVeno Medical overvalued?
        According to Wall Street analysts enVVeno Medical’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does enVVeno Medical pay dividends?
          enVVeno Medical does not currently pay dividends.
          What is enVVeno Medical’s EPS estimate?
          enVVeno Medical’s EPS estimate is -$0.4.
            How many shares outstanding does enVVeno Medical have?
            enVVeno Medical has 13,317,000 shares outstanding.
              What happened to enVVeno Medical’s price movement after its last earnings report?
              enVVeno Medical reported an EPS of -$0.24 in its last earnings report, expectations of -$0.24. Following the earnings report the stock price went down -2.832%.
                Which hedge fund is a major shareholder of enVVeno Medical?
                Among the largest hedge funds holding enVVeno Medical’s share is Perceptive Advisors LLC. It holds enVVeno Medical’s shares valued at 3M.
                  ---

                  Company Description

                  enVVeno Medical

                  Hancock Jaffe Laboratories, Inc. is a development stage medical device company, which develops biologic-based solutions that are designed to be life sustaining or life enhancing for patients with cardiovascular disease, and peripheral arterial and venous disease. Its products include The Bioprosthetic Heart Valve, The CoreoGraft, and The Venous Valve. The company was founded by Norman Jaffe on December 22, 1999 and is headquartered in Irvine, CA.
                  ---
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Medtronic
                  Abbott Labs
                  Boston Scientific
                  Becton Dickinson
                  Popular Stocks
                  ---
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis